Clinical Trials Directory

Trials / Completed

CompletedNCT05119777

HArmonyCa Injectable Gel for Mid Face Soft Tissue Augmentation

Prospective, Open Label, Post Marketing Study of the Safety and Effectiveness of HArmonyCa Injectable Gel for Mid-face Soft Tissue Augmentation

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
140 (actual)
Sponsor
Allergan · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Prospective, open label, post marketing study of the safety and effectiveness of HArmonyCa injectable gel for mid-face soft tissue augmentation

Conditions

Interventions

TypeNameDescription
DEVICEHArmonyCa Injectable GelSubdermal or deep dermal injection

Timeline

Start date
2021-10-13
Primary completion
2023-09-15
Completion
2023-09-15
First posted
2021-11-15
Last updated
2024-09-19

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05119777. Inclusion in this directory is not an endorsement.